Pharmaron Beijing (HKG:3759) has an average rating of buy and mean price target of HK$29.89, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)